Features Screener Stocks Charts
Sign In Sign Up

Vinati Organics Limited Fundamental Analysis Revenue, Profits & Valuation

NSE: VINATIORGA | BSE: 524200 | CHEMICALS
Price ₹1,304.50 ₹9.80 (-0.75%)
P/E Ratio 33.4 TTM
52-Week Range
Low ₹1,203 High ₹2,040
Market Cap ₹135.23B Billion
ROE 14.5% Annual

Market data as of Jun 3, 2026

This analysis examines Vinati Organics Limited (VINATIORGA) through the lens of its financial statements, valuation metrics, and institutional ownership patterns.

Vinati Organics Revenue Trend

Vinati Organics Limited managed to grow its top line 18.2% in FY2025, with revenue hitting ₹2,292 Cr.

A 11.5% CAGR over 10 years puts Vinati Organics Limited in solid growth territory. The top line went from ₹772 Cr to ₹2,292 Cr in that span.

Vinati Organics Limited is a mid-sized chemicals company by revenue, with a top line of ₹2,292 Cr.

Revenue Trend
YearRevenueYoY %
FY2025₹2,292 Cr+18.2%
FY2024₹1,939 Cr-10.1%
FY2023₹2,157 Cr+28.7%
FY2022₹1,676 Cr+71.0%
FY2021₹980 Cr
Revenue Trend (₹ Cr)

View Vinati Organics Limited's full 10-year revenue trend with CAGR analysis →

Vinati Organics Profitability

Year-over-year, net profit grew 25.5% from ₹323 Cr to ₹405 Cr in FY2025 for Vinati Organics Limited.

Net margin expanded to 17.7% in FY2025, up from 16.7% a year prior.

FY2025 diluted EPS of ₹39.09 was up from the ₹31.15 reported in FY2024.

Net Profit Trend (₹ Cr)

Is Vinati Organics Undervalued

The P/E Ratio approach puts Vinati Organics Limited's intrinsic value at ₹2,126, a 62.9% upside from the current market price.

Vinati Organics Limited shares are currently trading at ₹1,304.50.

Craytheon also calculates intrinsic value using the EPS Growth model. The full breakdown with assumptions is available in the detailed analysis.

Valuation Models
ModelEst. Fair Valuevs. Current Price
P/E Ratio₹2,12662.9% upside to fair value
EPS GrowthUpgradeUpgrade

See all valuation models for Vinati Organics Limited with detailed assumptions →

Vinati Organics Shareholding Pattern

Promoter holding is steady at 74.3% — no buying or selling over the past 4 quarters.

On the foreign institutional side, the holding is 3.7% as of March 2026 — down from 3.9%.

The DII stake stands at 9.9% as of March 2026, versus 9.2% in the year-ago period.

Shareholding Pattern (Last 4 Quarters)
QuarterPromoterFIIDIIPublic
Mar 202674.3%3.7%9.9%12.1%
Dec 202574.3%3.8%9.8%12.1%
Sep 202574.3%3.8%9.6%12.4%
Jun 202574.3%3.9%9.2%12.6%

Track quarterly shareholding changes for Vinati Organics Limited →

Vinati Organics Balance Sheet

Proportional view as of 3 Jun 2026. Hover blocks for details.

Assets

Liabilities & Equity

In FY2025, the total asset base came in at ₹32.79B, up 15.5% YoY from ₹28.40B.

Property, Plant & Equipment accounts for 65.9% of the total, ahead of Receivables (18.1%) and Other Assets (8.1%).

Capital structure: 85.2% equity, 1.9% debt, 12.9% operating liabilities. Over the year, debt is up 1,246.9% and equity is up 13.5%.

Balance sheet composition — FY 2025

Assets (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Cash & ST Investments 104.90M
Receivables 5.92B
Inventories 2.21B
Property, Plant & Equipment 21.62B
Investments 258.90M
Intangibles & Goodwill 4.40M
Other Assets 2.67B
Liabilities and equity (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Equity 27.93B
Short-term Debt 626.30M
Trade Payables 1.48B
Other Liabilities 2.75B

View full balance sheet (multi-year) →

Vinati Organics Investment Snapshot

Here's the bottom line on Vinati Organics Limited (VINATIORGA) based on the latest available financials.

Revenue of ₹2,292 Cr in FY2025, up 18.2% year-over-year.

Long-term revenue has been compounding at 11.5% annually over 10 years.

The company is profitable, with a net margin of 17.7% and net income of ₹405 Cr.

The P/E Ratio model implies 62.9% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.

Unlock Full Analysis

Get the complete view of Vinati Organics Limited on Craytheon — 10 years of financials, three valuation models, and institutional holding trends.

Related Stocks